Riluzole treatment modulates KCC2 and EAAT-2 receptor expression and Ca2+ accumulation following ventral root

Krisztián Pajer1, Tamás Bellák1, Tímea Grósz2

  • 1Department of Anatomy, Histology and Embryology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.

Insights

Riluzole treatment enhanced motoneuron survival after spinal root avulsion by reducing excitotoxicity. It prevented increased intracellular calcium and decreased EAAT-2 expression, but not KCC2 downregulation.

Area of Science:

  • Neuroscience
  • Spinal Cord Injury Research
  • Neuroprotection

Background:

  • Avulsion injuries lead to motoneuron death via excitotoxicity in spinal cord segments.
  • Understanding molecular changes, including receptor expression, is crucial for developing treatments.
  • Riluzole, a neuroprotective agent, blocks voltage-activated Na+ and Ca2+ channels.

Purpose of the Study:

  • To investigate short and long-term molecular and receptor expression alterations linked to excitotoxicity after spinal root avulsion.
  • To evaluate the effects of riluzole treatment on these changes and motoneuron survival.

Main Methods:

  • Avulsion of L4, 5 ventral roots in an experimental model.
  • Riluzole administration for 2 weeks in treated animals.
  • Confocal and dSTORM imaging to detect EAAT-2 and KCC2 expression.
  • Electron microscopy to quantify intracellular Ca2+ levels.

Main Results:

  • Riluzole significantly enhanced motoneuron survival.
  • KCC2 expression was downregulated in injured motoneurons, irrespective of riluzole treatment.
  • Riluzole prevented the rise in intracellular calcium and the decrease in astrocytic EAAT-2 expression.

Conclusions:

  • KCC2 downregulation may not be essential for injured motoneuron survival.
  • Riluzole effectively modulates intracellular calcium levels and EAAT-2 expression in astrocytes.
  • Riluzole demonstrates significant neuroprotective effects against excitotoxicity in spinal avulsion injuries.